Evaluation Of Antibiotic Use In Diabetic Ulcer Patients Based On The Defined Daily Dose Method (Ddd)

As Syifa Roidhotul Jannah Putri Widi; Avianti Eka Dewi Aditya  Purwaningsih; Novita  Sari

doi:10.35451/8nffcw16

Authors

As Syifa Roidhotul Jannah Putri Widi Universitas Setia Budi Surakarta
Avianti Eka Dewi Aditya Purwaningsih Universitas Setia Budi Surakarta
Novita Sari Universitas Setia Budi Surakarta

DOI:

https://doi.org/10.35451/8nffcw16

Keywords:

Antibiotik, ATC/DDD, DU 90%, Ulkus Diabetikum

Abstract

Diabetic ulcers are a complication of diabetes mellitus that manifest as open skin wounds on the feet due to blood vessel disorders and nerve damage. These ulcers are susceptible to infection because bacteria thrive in high glucose environments. Selecting the right antibiotic is crucial in treating these infections. This study aims to predict the pattern of antibiotic prescribing in patients with diabetic ulcer infection in Hospital X Semarang Regency in 2023 using the ATC (Anatomical Therapeutic Chemical) method and DDD (Defined Daily Dose) units. This study is a retrospective descriptive study that analyzes data on diabetic ulcer patients who received antibiotic therapy between January-December 2023. The data collection technique was carried out by purposive sampling, following the inclusion and exclusion criteria. The results of the study of 168 patients with Diabetic Ulcers were found to be more dominant in female patients 53.57% (90 patients) and male patients 46.43% (78 patients). The antibiotic research that was classified as having the highest DDD/100 patient-days value was Ceftriaxone 44.99 DDD, followed by Metronidazole 33.96 DDD and Levofloxacin 26.85 DDD. Meanwhile, antibiotics that were included in the DU 90% segment with the order of highest to lowest values were Ceftriaxone (36.16%), Metronidazole (63.46%), and Levofloxacin (85.04%). The use of antibiotics in diabetic ulcer patients based on the ATC/DDD and DU 90% methods needs to be reviewed periodically because it has the potential to cause the risk of resistance in patients which will then prolong the healing process. Based on the evaluation of antibiotic consumption patterns in diabetic ulcer patients at Hospital X, Semarang Regency in 2023 using the ATC/DDD and DU 90% methods, the antibiotics with the highest DDD/100 patient-days were Ceftriaxone (44.99), followed by Metronidazole (33.96) and Levofloxacin (26.85). These three antibiotics are included in the DU 90% segment, therefore their use needs to be periodically evaluated to ensure the rationality of therapy and to prevent the occurrence of antibiotic resistance.

Downloads

Download data is not yet available.

References

Satria Nugraha MH, Wahyuni N, Sita Saraswati PA. Efektivitas Low Power Laser Terapi Dan Proprioceptif Neuromuscular Facilitation Pada Ulkus Diabetikum Derajat 2. Sport Fit J. 2019;43–50.

2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis†. Ann Med. 2017;49(2):106–16.

3. Riset Kesehatan Dasar. Hasil Utama Riskesdas 2018. Kementrian Kesehatan Republik Indonesia; 2018.

4. Jakosz N. Book review – IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease. Wound Pract Res. 2019;27(3):144.

5. Yekta Z, Pourali, Ghasemi-rad M, Ravanyar, Nezhadrahim. Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer. Diabetes, Metab Syndr Obes Targets Ther. 2011;371.

6. Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Evaluasi Penggunaan Obat di Fasilitas Kesehatan. Jakarta: Kementrian Kesehatan Republik Indonesia; 2017.

7. Kornelia S, Aryzki S, Mukti YA, Salwati. Evaluasi Penggunaan Antibiotik Pada Pasien Ulkus Diabetikum Rawat Jalan di RSUD Ulin Banjarmasin. J Kesehat Unggul Gemilang. 2024;8.

8. Sidabalok R, Aris W. Valuasi Penggunaan Antibiotik Dengan Metode Defined Daily Dose (DDD) Pada Pasien Ulkus Diabetikum di Rawat Inap RSUD Sleman. J Farm dan Kesehat Indones. 2022;2(2):26–36.

9. Meirita E, Sari A. Evaluasi Rasionalitas Penggunaan Antibiotik Pada Pasien Penyakit Diabetes Melitus Tipe II Di Instalasi Rawat Inap Rumah Sakit Grandmed Lubuk Pakam Tahun 2022. J Farm. 2022;5(1):73–9.

10. Putri L, Gayatri Y, Yunariyah B, Jannah R, Ningsih WT, Mellitus D, et al. Pengetahuan Penderita Diabetes Melitus Tentang Pencegahan Ulkus Diabetikum Di Wilayah Kerja Puskesmas Sumurgung Kabupaten Tuban. J Ilmu Kesehat Mandira Cendikia. 2024;3(9):29–41.

11. Zikransyah TMH, Rizal F, Mustaqim MH. Hubungan Jenis Kelamin dengan Kejadian Ulkus Diabetikum di RSUD Meuraxa Banda Aceh. Media Kesehat Masy Indones. 2023;22(5):291–5.

12. Murni L, Suryati I, Guslina IA. Efektifitas Kompres Metronidazol Dan Nacl 0,9% Terhadap Penyembuhan Luka Pasien Dengan Ulkus Diabetikum. J Kesehat Tambusai. 2024;5(2):5442–57.

13. Salim MF, Lubis IK, Sugeng S. Perbedaan Length of Stay (LOS) Pasien Diabetes Mellitus Berdasarkan Komplikasi Di RSUP Dr. Sardjito Yogyakarta. J Manaj Inf Kesehat Indones. 2019;7(1):17.

14. Ivana, Purwaningsih AEDA, Chunaesiana FS. Evaluasi Penggunaan Antibiotik Pasien Rawat Inap Rumah Sakit X Semarang Tahun 2023 dengan Metode Kuantitatif Evaluation of Inpatient Antibiotic Use at Hospital X , Semarang Regency , in 2023 Using Quantitative Methods. J Farm. 2025;8(1):198–206.

15. Mahmudah F, Sumiwi SA, Hartini S. Study of the Use of Antibiotics with ATC/DDD System and DU 90% in Digestive Surgery in Hospital in Bandung. Indones J Clin Pharm. 2016;5(4):293–8.

16. Wahyudi AE, Fadraersada J, Masruhim MA. Evaluasi Penggunaan Antibiotik Berdasarkan Metode Defined Daily Dose (DDD) Pada Pasien Ulkus Daibetikum. Mulawarman Pharm Conf. 2018;8:21–9.

17. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132–73.

18. National Institute for Health and Care Exellent. Diabetic Foot Problems Prevention and Management. Natl Inst Heal Care Excell. 2015;19.

19. Raini M. Antibiotik Golongan Fluorokuinolon. Media Penelit dan Pengemb Kesehat. 2017;26(3):163–74.

20. World Health Organization. Guidelines for ATC Classification and DDD Assignment. 16th ed. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health; 2013.

21. Saragi S, Martirini AS. Penggunaan Antibiotik Pasien Bedah Digestif dengan Metode Anatomical Therapeutic Chemical-Defined Daily Dose Antibiotic Use in Digestive Surgery Patients with the Anatomical Therapeutic Chemical-Defined Daily Dose Method. J Farm. 2025;8(1):18–27.

22. Pradipta IS, Ronasih E, Kartikawati AD, Hartanto H, Amelia R, Febrina E, et al. Three years of antibacterial consumption in Indonesian Community Health Centers: The application of anatomical therapeutic chemical/defined daily doses and drug utilization 90% method to monitor antibacterial use. J Fam Community Med. 2015;22(2):101–5.